Ryufin

Elementis plc

United Kingdom · GB0002418548 · reports in USD · Europe

The answers

From the annual report for the year to Dec 31, 2025. Each line says what it is based on.

Is it growing?Fair
Revenue −1.0% in the year to Dec 31, 2025, on the year before.
Is it a good business?To watch
It earned −7.1% on its shareholders' equity in the year to Dec 31, 2025.
Is it safe?Good
Equity is 58% of its assets, and operations brought in cash in the year.
Is the price fair?n/a
Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.

The year

Year to Dec 31, 2025, consolidated, in USD.

$598M

revenue

18%

operating margin

−$46M

net profit

Year by year

As filed; an earlier year can differ from its own report when the company restated it.

Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$736M$713M$604M$598M
Operating profit−$42M$59M$96M$109M
Net profit to shareholders−$51M$27M−$48M−$46M
Earnings per share−$0.09$0.04−$0.08−$0.08
Dividend per sharen/a$0.02n/an/a
Cash from operations$77M$77M$100M$74M
Capital spending$33M$38M$17M$22M
Cash$55M$66M$60M$55M
Total assets$1.6B$1.5B$1.3B$1.1B
Equity$784M$847M$757M$644M

What they do

In the company's own words, from the annual report.

Our products don’t have everyday names, but there is a little bit of Elementis in many everyday items. We create specialty chemicals using our deep expertise in the science of how materials flow and feel (rheology) and in combining ingredients in the right way to make products that perform better, feel nice and last longer (formulation solutions). This helps us to deliver crucial end-product attributes for our customers in the personal care and coatings markets.

Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.